Aeon
Connecting Sign in

Every public trading filing, minutes after it lands, in plain words.

Get alerts

← Feed

AKBANasdaq

Akebia Therapeutics, Inc.

Alert me on AKBA
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

No purchase or sale on this ticker by a member of Congress or an insider yet.

Filings for AKBA

18 held · newest 518 held · newest 2
Loading the filings.
See all 18 filings for AKBA

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
$280KQ3 2025
$260KQ4 2025
$480KQ1 2026
$360KQ2 2026
Down 25 percent from Q1 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov on Sep 23, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.